Blog

Jun 17, 2019

Anti-aging compound from pomegranates proves promising in human clinical trials

Posted by in categories: biotech/medical, life extension

Since aging is a key driver of many diseases, targeting that process could be a handy catch-all for treating a range of diseases and improving quality of life for pretty much everybody. Researchers at EPFL have now reported a new step towards that goal, with human clinical trials of a fruit-derived compound showing promise in slowing mitochondrial aging in elderly patients, with no side effects found.

Leave a reply